Ποια είναι η τιμή για GeneFerm Biotechnology Co., Ltd. (1796)

Η τιμή για GeneFerm Biotechnology Co., Ltd. (1796) είναι $0.93330147

Ποια είναι η κεφαλαιοποίηση αγοράς για GeneFerm Biotechnology Co., Ltd. (1796)

Η κεφαλαιοποίηση αγοράς για GeneFerm Biotechnology Co., Ltd. (1796) είναι $38.69M

GeneFerm Biotechnology Co., Ltd. (1796) Τιμή και Κεφαλαιοποίηση Αγοράς

GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.

Η τιμή για 1796	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$128,004 $38.69M	NVDA	$5.307T	+13,715,068.62%
$113,301 $38.69M	AAPL	$4.697T	+12,139,665.34%
$100,021 $38.69M	GOOG	$4.147T	+10,716,768.52%
$86,436.61 $38.69M	MSFT	$3.584T	+9,261,281.84%
$68,366.03 $38.69M	AMZN	$2.834T	+7,325,082.20%

Η τιμή για 1796

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$128,004 $38.69M